EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹2.00 Cr | ₹4.52 Cr | ₹4.15 Cr | ₹3.89 Cr | ₹3.58 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of EVEREST ORGANICS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹2.00 Cr |
| Mar2024 | ₹4.52 Cr |
| Mar2023 | ₹4.15 Cr |
| Mar2022 | ₹3.89 Cr |
| Mar2021 | ₹3.58 Cr |
How is Deferred Tax Assets / Liabilities of EVEREST ORGANICS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.00 Cr | -55.63 | |
| Mar2024 | ₹4.52 Cr | 8.95 | |
| Mar2023 | ₹4.15 Cr | 6.61 | |
| Mar2022 | ₹3.89 Cr | 8.54 | |
| Mar2021 | ₹3.58 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹405.7 Cr | 0.7% | -12.1% | 55.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹393,323.0 Cr | 1.7% | -5.7% | -7.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,825.0 Cr | 0.8% | -6.7% | 3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,349.0 Cr | 0.6% | 4.3% | 24.4% | Stock Analytics | |
| CIPLA | ₹106,048.0 Cr | -4.7% | -12.3% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,494.0 Cr | 6.3% | -2.1% | -4.1% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | 0.7% |
-12.1% |
55.2% |
| SENSEX | -1.7% |
-4.3% |
6.2% |
You may also like the below Video Courses